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Abstract 
Introduction and objectives. Some electrocardiographic patterns are associated with an increased risk of sudden 
cardiac death due to ventricular arrhythmias. There is no information on the prevalence of these patterns in the 
general population in Spain. The objective of this study was to analyze the prevalence of these patterns and 
associated clinical and epidemiological factors. 
Methods. This subanalysis of the OFRECE study selected a representative sample of the Spanish population 
aged ≥ 40 years. We studied the presence or absence of electrocardiographic patterns of Brugada syndrome and 
QT interval abnormalities. Clinical data and electrocardiograms were available in all participants. 
Electrocardiograms were evaluated by 2 cardiologists and a third cardiologist was consulted if there was 
disagreement in the diagnosis. We calculated the weighted prevalence and clinical factors associated with the 
presence of Brugada-type patterns or QT segment abnormalities. 
Results. Overall, 8343 individuals were evaluated (59.2 years, 52.4% female). There were 12 Brugada cases 
(type 1, 2 cases; type 2, 10 cases; weighted prevalence, 0.13%). For corrected QT (QTc) analysis, we excluded 
participants with left bundle branch block or without sinus rhythm. Weighted prevalences were as follows: short 
QTc (< 340 ms) 0.18%, borderline QTc (441-469 ms) 8.33%, long QTc (≥ 470 ms criterion) 1.01% and long 
QTc (≥ 480 criterion) 0.42%. 
Conclusions. A total of 0.6% to 1.1% of the Spanish population aged ≥ 40 years has an electrocardiographic 
pattern associated with a higher risk of sudden death (Brugada syndrome, long QT, or short QT). 
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Resumen 
Introducción y objetivos. Hay patrones electrocardiográficos asociados a mayor riesgo de muerte súbita por 
arritmias ventriculares. En España no existe información acerca de su prevalencia en la población. El objetivo es 
estudiar la prevalencia de estos patrones, así como los factores clinicoepidemiológicos asociados a su presencia. 
Métodos. Subanálisis del estudio OFRECE en el que se estudió la prevalencia de patrones electrocardiográficos 
de síndrome de Brugada o anomalías del intervalo QT en una muestra representativa de la población española ≥ 
40 años. Se dispuso de datos clínicos y electrocardiogramas de todos los participantes. Los electrocardiogramas 
fueron evaluados de forma independiente por 2 cardiólogos y, en caso de desacuerdo, se consultó con un tercero. 
Se analizaron las prevalencias ponderadas y los factores clínicos asociados a patrones tipo Brugada o a 
anomalías del segmento QT. 
Resultados. Se evaluó a 8.343 individuos (59,2 años, 52,4% mujeres) y se detectaron 12 casos de patrón Brugada 
(tipo 1, 2 casos; tipo 2, 10 casos; prevalencia ponderada, 0,13%). Para el análisis del QT corregido (QTc) se 
excluyó a los participantes con bloqueo de rama izquierda o ritmos no sinusales. Las prevalencias ponderadas 
fueron: QTc corto (< 340 ms) 0,18%, QTc borderline (441-469 ms) 8,33%, QTc largo (criterio ≥ 470 ms) 1,01% 
y QTc largo (criterio ≥ 480 ms) 0,42%. 
Conclusiones. El 0,6-1,1% de la población española de edad ≥ 40 años presenta un patrón electrocardiográfico 
de riesgo de muerte súbita (síndrome de Brugada, QT largo o QT corto). 
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INTRODUCTION  
In the past 20 years, some clinical and electrocardiographic syndromes have been found to be 
associated with a higher risk of sudden cardiac death (SCD) due to ventricular arrhythmia, such as 
Brugada syndrome
1, 2, 3, 4
 or short QT syndrome.
5, 6
 Other conditions, such as long QT syndrome,
7, 8
 
were already known and have been described in more detail. These diseases can develop 
asymptomatically for years, and the prevalence reported by various European studies ranges from 0% 
to 6%
9, 10
 for Brugada patterns and 0% to 0.5% for short QT interval.
11
 Prevalence studies on long QT 
interval in the general population are highly heterogeneous, with differences in populations and 
cutoff points. In clinical practice, long QT syndrome is the most common arrhythmic disorder 
associated with SCD (35.6%), followed by Brugada syndrome (32.1%).
12
 The aim of this study was 
to investigate a representative sample of the Spanish population to estimate the prevalence of 
electrocardiographic patterns consistent with Brugada types 1 and 2, long QT interval, and short QT 
interval. 
METHODS  
This project was a substudy of the OFRECE project (Spanish acronym for Observation of 
Fibrillation and Coronary Disease in Spain) approved by the Clinical Research Ethics Committee at 
the University Hospital of Basurto and by other hospital or regional committees. The aim was to 
determine the prevalence of atrial fibrillation (AF) and stable angina in the Spanish population ≥ 40 
years. This cross-sectional study was sponsored by the Research Agency of the Spanish Society of 
Cardiology and was conducted in the Spanish population ≥ 40 years assigned to a primary care 
physician. The study methodology and results have already been described in previous 
publications.
13, 14
 The primary care physician invited randomly-selected patients (11 831) to 
participate in the study, 76% of whom accepted. All participants (n = 8400) gave written informed 
consent. 
  
The flow chart for OFRECE study participation is described in previous publications.
13, 14
 The 
study was started in Spain in March 2010 and completed in October 2012. All participants were 
examined by their primary care physician, who completed a form on cardiovascular risk factors and 
medical history. Patients then underwent an electrocardiogram (ECG), and their weight, height, and 
blood pressure (2 measurements) were measured according to the World Health Organization 
recommendations described in the current European Society of Cardiology guidelines.
15
 When an 
undiagnosed heart disease was suspected, an appointment was made for the participant with the 
coordinating cardiologist. The risk factors and medical history analyzed were defined according to 
the predefined guidelines of the American College of Cardiology/American Heart Association,
16
 
which are attached in Appendix 2 of the supplementary material. A total of 57 people were 
withdrawn from the analysis due to a lack of key information or an unevaluable ECG, giving a final 
sample of 8343 people. 
 
All ECGs were read at a central location by a group of 9 cardiologists. The ECGs were randomly 
assigned to each cardiologist, who performed the initial reading. Afterwards, a second cardiologist 
independently reviewed all tracings. When they disagreed about a patient, a third observer was 
included and the final diagnosis was reached by consensus. The diagnostic criteria for each 
abnormality analyzed are described below. 
Corrected QT-QT Interval  
Absolute QT interval was measured by hand in leads IIand V5. When II or V5 measurements were 
impossible, the interval was taken from V4 or V6 or any lead in which it was more readily defined. 
Automatic measurement was not considered for 2 reasons: a) it was not available in all 
electrocardiographs used in the study and b) electrocardiographs equipped with automatic 
measurement options used different algorithms. The Bazett formula (QTc = QT/√RR) was used to 
calculate the corrected QT (QTc). Although this formula has limitations (tendency to overestimate 
QT above 100 beats), it is the most used commonly formula and, therefore, the results can be 
compared with those of other previously published studies. To analyze QTc intervals in the study 
population, several categories were established based on available clinical evidence, particularly in 
terms of prognosis. The long QT categories used are those described by Goldenberg et al.,
17
 where 
the short QTc categories taken as a reference are those by Anttonen et al.
18
: 
 
 Normal QTc: 340-439 ms 
 Borderline QTc: 440-469 ms 
 Long QTc: ≥ 470 ms17, 19, 20, 21 
 Short QTc: 321-339 ms 
 Very short QTc: ≤ 320 ms11, 18, 22, 23. 
 
The analysis excluded individuals with complete left bundle-branch block or with paced or 
nonsinus rhythms. 
 
Once the results were obtained, the new European Society of Cardiology guidelines on ventricular 
arrhythmia and sudden cardiac death,
24
 which establish a cutoff for long QT ≥ 480 ms (class I, level 
of evidence C). Consequently, the study population data were also reanalyzed with this cutoff point. 
  
Brugada-type Electrocardiographic Patterns  
Brugada 1 and 2 electrocardiographic patterns were defined according to the 2002 consensus 
document
2
: 
 
 Type 1 or coved pattern: convex-descending ST-segment elevation ≥ 2 mm in more than 1 right 
precordial lead, followed by negative T-wave. 
 Type 2 or saddleback pattern: concave ST-segment elevation ≥ 2 mm in more than 1 right 
precordial lead, followed by positive or isobiphasic T waves. 
Statistical Analysis  
Because the sampling process meant that individuals in the population had differing probabilities 
of being selected, each participant in the final sample was assigned a weight that represented the 
number of persons from the Spanish population having the same sex, age bracket, and geographic 
area.
25
 Therefore, the sum of all weights of the sample was equal to the size of the Spanish population 
≥ 40 years. This weighting process was complex and was undertaken in 2 phases, using the 
methodology described in previous reports on the OFRECE study
13, 14
 combined with the procedure 
proposed by Deville and Särndal
26
 with the “Calibrate” instruction of the Stata statistical package 
(version 10.1). The 2011 municipal census of inhabitants by sex, age bracket, and geographic area 
was used as the population for the adjustment and calibration. 
 
All analyses were performed in keeping with the sample design of the study. For all variables 
analyzed, specific prevalences were calculated by sex and age bracket along with the respective 95% 
confidence intervals (95%CI). 
 
To identify the factors associated with the abnormalities of interest, odds ratios were estimated 
after adjustment for age and sex by logistic regression models. A multivariable model including 
factors with P < .1 in the previous analysis was subsequently fitted to identify factors independently 
associated with the conditions of interest. 
 
Interobserver variability was also analyzed, and agreement was very high in all cases, above 99%. 
In terms of the consistency of Brugada-type patterns, expected agreement was 0.9947 and observed 
agreement was 0.9976. The Kappa index was 0.5444 (95%CI, 0.3667-0.7220). In the case of QTc, 
cases were noted and reviewed if the observer and reviewer measurements were more than 10 ms 
apart (higher observer measurement, n = 172; higher reviewer measurement, n = 37). A third 
measurement was performed by both, and an agreement was reached. In all other cases (discrepancy 
≤ 10 ms), the average value was recorded in the database. These discrepancies in 209 (2.5%) pairs of 
measurements had a lower clinical impact because only 7 (0.08%) would have changed the patient 
classification in terms of QTc duration. 
  
RESULTS  
QT Abnormalities  
A total of 8343 participants completed the protocol, but only 7889 met the inclusion criteria for 
this analysis (native sinus rhythm and no left bundle-branch block). A total of 243 participants were 
excluded for AF, 135 for left bundle-branch block, 24 for both conditions, and 52 for nonsinus or 
unnatural rhythm. Of these, 52.5% were women with a mean age of 58.3 years. Most of the 
population (7011 individuals) had a normal QTc interval, thus accounting for 88.9% and for 90.5% 
when weighted by age and sex (95%CI, 89.5-91.5). In this group, mean QTc was 403.8 ms (95%CI, 
402.6-405.0). A total of 763 people had borderline QTc (prevalence of 9.7%; weighting, 8.3%; 
95%CI, 7.4-9.3). Mean QTc was 449.3 ms (95%CI, 448.5-450.0). A total of 96 participants had a 
long QTc interval (cutoff ≥ 470 ms) (gross prevalence, 1.22%; weighted prevalence, 1.01%; 95%CI, 
0.68-1.34). In this group, mean QTc was 484.9 ms (95%CI, 480.2-489.6). Last, 51 participants had a 
QTc ≥ 480 ms, with a prevalence of 0.65% and a weighted prevalence of 0.42% (95%CI, 0.26-0.57). 
Mean QTc was 499.48 ms (95%CI, 493.11-505.85). A total of 18 patients had short QTc interval 
(mean QTc, 333.7 ms; 95%CI, 331.6-335.9), for a prevalence of 0.23% and when weighted by age 
and sex, 0.18% (95%CI, 0.08-0.29). No patients had very short QTc interval. The characteristics of 
the population and of participants with QTc disorders are listed in Table 1. The multivariable analysis 
for QTc disorders (Table 2) showed that age and a history of AF were independently associated with 
the presence of long QT (cutoff ≥ 470 ms). Hypertension was strongly associated in the univariable 
analysis. A multivariable analysis with cutoff ≥ 480 ms also identified AF as an independent 
predictive factor of long QTc. The predictive factors for borderline QTc were age, female sex, 
hypertension, and diabetes mellitus. The association analysis excluded the patient group with short 
QTc due to its small size. 
  
Table 1. Characteristics of the Population With Normal Corrected QT. Population Comparisons: Normal Corrected QT With 
Borderline Corrected QT, Normal Corrected QT With Corrected QT > 470 ms, and Normal Corrected QT With Corrected QT > 
480 ms 
 
Normal  
(n = 7011)  
Borderline  
(n = 763)  
P  
Normal  
(n = 7011)  
QTc > 470 
(n = 96)  
P  
Normal  
(n = 7011)  
QTc > 480 
(n = 51)  
P  
 
Sex, %  
Men  48.3  38.7  
.002  
48.3  53.1  
.570  
48.3  52.4  
.661  
Women  51.7  61.3  51.7  46.9  51.7  47.6  
Age bracket, %  
40-49 years  33.9  21.9  
< .001  
33.9  6.3  
< .001  
33.9  10.1  
< .001  
50-59 years  25.9  24.3  25.9  18.5  25.9  4.1  
60-69 years  19.2  19.9  19.2  29.3  19.2  26.4  
70-79 years  13.6  17.9  13.6  17.6  13.6  31.9  
≥ 80 years  7.4  16.8  7.4  28.4  7.4  27.4  
CVRF  
Obesity, %  32.4  42.4  .002  32.4  43.9  .029  32.4  31.4  .892  
Excess weight, %  42.4  39.9  .353  42.4  31.8  .068  42.4  28.4  .094  
BMI, mean, kg/m2  28.3  98.4  .003  28.3  28.9  .311  28.3  27.2  .294  
Hypercholesterolemia, %  23.7  30.2  .006  23.7  30.0  .218  23.7  28.6  .496  
Diabetes, %  10.7  19.1  < .001  10.7  14.2  .317  10.7  22.3  .016  
Current smoker, %  23.4  21.9  .523  23.4  12.5  .073  23.4  9.3  .073  
HT, %  42.0  57.3  < .001  42.0  72.1  < .001  42.0  63.1  .039  
SBP, mean, mmHg  129.8  137.2  < .001  129.8  138.4  < .001  129.8  136.4  .034  
DBP, mean, mmHg  77.7  80.0  < .001  77.7  79.9  .138  77.7  76.5  .404  
History, %  
Stroke  3.2  3.0  .839  3.2  8.0  .016  3.2  6.6  .226  
Peripheral artery disease  2.1  2.7  .331  2.1  5.2  .052  2.1  7.6  .017  
Chronic lung disease  5.5  7.2  .154  5.5  14.1  .015  5.5  26.2  < .001  
Thyroid condition  6.7  8.6  .226  6.7  8.2  .638  6.7  7.8  .777  
Pacemaker/ICD implantation  0.2  0.4  .218  0.2  7.3  < .001  0.2  3.0  < .001  
Ischemic heart disease  4.2  3.9  .773  4.2  8.5  .041  4.2  14.4  .001  
Prior diagnosis of HF  1.6  3.4  .015  1.6  5.2  .011  1.6  3.8  .160  
Atrial fibrillation  1.1  1.6  .230  1.1  6.1  < .001  1.1  13.0  < .001  
          
 
BMI, body mass index; CVRF, cardiovascular risk factors; DBP, diastolic blood pressure; HF, heart failure; HT, hypertension; 
ICD, implantable cardioverter defibrillator; QTc, corrected QT; SBP, systolic blood pressure. 
  
Table 2. Multivariable Analysis of the Population With Corrected Borderline QT Compared With 
Normal QT and of the Population with Corrected QT > 470 ms Compared With Normal QT 
 
OR  95%CI  P  
    
Population with borderline QTc compared with population with normal QTc  
Age, y  1.02  1.01-1.03  < .001  
Female  1.48  1.16-1.89  .002  
Diabetes mellitus  1.51  1.16-1.98  .003  
Hypertension  1.36  1.07-1.71  .010  
Population with QTc > 470 ms compared with population with normal QTc  
Age, y  1.06  1.04-1.09  < .001  
Atrial fibrillation  3.46  1.32-9.03  .010  
    
 
95%CI, 95% confidence interval; OR, odds ratio; QTc, corrected QT. 
Brugada-type Electrocardiographic Patterns  
The Brugada ECG pattern analysis considered the data of 8343 individuals in the study, 
identifying 12 patients with Brugada 1 and 2 patterns: 
 
 Two patients had Brugada type 1 (2 women aged 55 and 54 years), giving a prevalence of 
0.024%, or 0.01% when weighted (95%CI, 0.00-0.04). 
 Ten patients had Brugada type 2, yielding a prevalence of 0.12%, or 0.17% when weighted by age 
and sex (95%CI, 0.02-0.33). Eight of these were men; mean age of the group was 55.4 years. 
 
Table 3 shows the clinical characteristics of participants with an electrocardiographic pattern 
consistent with Brugada 1 and 2 compared with those of the general population. The geographic 
distribution of patients is shown in Figure. 
  
Table 3. Characteristics of the Population With and Without Brugada Syndrome (Types 1 and 2) 
 
Brugada 1 and 2 P  
   All (n = 8343)  Yes (n = 12)  No (n = 8331)     
 
Sex, %  
Men  47.6  50.0  47.6  
.785  
Women  52.4  50.0  52.4  
Age bracket, %  
40-49 years  31.2  21.7  31.2  
.165  
50-59 years  24.6  36.1  24.5  
60-69 years  19.3  5.7  19.3  
70-79 years  14.9  0.0  14.9  
≥ 80 years  10.1  36.5  10.0  
CVRF  
Obesity, %  33.8  13.2  33.9  .092  
Excess weight, %  42.1  69.7  42.0  .307  
BMI, mean, kg/m2  28.4  27.6  28.4  .293  
Hypercholesterolemia, %  25.4  10.7  25.4  .133  
Diabetes mellitus, %  12.2  0.0  12.2  .300  
Current smoker, %  22.3  8.7  22.4  .630  
Hypertension, %  45.3  51.8  45.3  .853  
SBP, mean, mmHg  130.9  139.1  130.8  .424  
DBP, mean, mmHg  77.8  76.1  77.8  .077  
History, %  
Stroke  3.8  0.0  3.8  .578  
Peripheral artery disease  2.4  0.0  2.4  .662  
Chronic lung disease  6.3  0.0  6.3  .462  
Thyroid condition  6.9  2.8  6.9  .254  
Pacemaker/ICD implantation  0.7  0.0  0.7  .829  
Ischemic heart disease  4.9  4.7  4.9  .704  
Prior diagnosis of CHF  3.1  0.0  3.1  .620  
Atrial fibrillation  4.4  0.0  4.4  .554 
     
 
BMI, body mass index; CHF, congestive heart failure; CVRF, cardiovascular risk factors; DBP, 
diastolic blood pressure; ICD, implantable cardioverter defibrillator; SBP, systolic blood 
pressure. 
 
  
 
 
 
Figure. Geographic distribution of the Brugada-type the electrocardiographic patterns found. 
DISCUSSION  
This cross-sectional study in a representative sample of the Spanish population aged ≥ 40 years 
found a prevalence of 0.01% for Brugada type 1 pattern, 1.01% for long QTc interval defined as ≥ 
470 ms or 0.42% when defined as ≥ 480 ms, and 0.18% for short QTc. Consequently, we found that 
electrocardiographic abnormalities associated with SCD were present in a nonnegligible percentage 
of the general population. Based on the results, it was estimated that 0.6% to 1.2% of the population ≥ 
40 years old has an electrocardiographic pattern associated with a higher risk of SCD. If patients with 
borderline QTc and Brugada type 2 pattern are also considered, this percentage would be nearly 10%. 
Patterns Associated With Brugada Syndrome  
 
The prevalence found for Brugada 1 and 2 patterns was low (0.13%), a finding consistent with the 
European series published after 2002 in Greece, Italy, and Turkey.
27, 28, 29
 In northern countries 
(Germany, Finland, and Denmark),
10, 30, 31
 the prevalence was low and no Brugada type 1 pattern was 
observed. In our study, it is noteworthy that the 2 cases of Brugada type 1 corresponded to 2 middle-
aged women, even though Brugada syndrome is traditionally considered to affect men more often, at 
a ratio of 8:1.
2
 In this regard, the findings of patients with Brugada type 2 patterns are more consistent 
with the medical literature (8 of the 10 patients reported were men). Our study determined prevalence 
only for individuals older than 40 years. However, in terms of prognosis, this selection bias may be of 
some importance because the above reviews report a mean age of 40 years for onset or diagnosis 
among affected patients. 
  
QT Abnormalities  
The prevalence of QT abnormalities was high. According to Goldenberg et al.,
17
 borderline QTc 
or QTc above 470 ms is associated with a higher risk of cardiac events. The prevalences found in this 
series are high: 8.3% and 1.01% (≥ 470 ms), respectively. Therefore, we can estimate that almost 4 
million people in Spain have some degree of QTc interval prolongation and are thus at risk of cardiac 
events. However, other studies have shown even higher prevalences. Veglio et al.
20
 reported a gross 
prevalence of 25.8% of people with QTc > 440 ms. This cohort was small and selective: all 
participants had type 2 diabetes, mean age was 65.4 years, and most were women. Because QTc 
elongation is significantly related to age, female sex, and a diagnosis of diabetes, this alone explains 
why these authors observed higher prevalences than those obtained in the present study. The 
Rotterdam study
21
 also found much higher prevalences than those obtained in our study: 18% had 
borderline QTc and 11.1% had long QTc. Again, the mean age of the population analyzed was higher 
and there were more women than men. Furthermore, the cutoff points used were much more 
restrictive than those used in our study; consequently, all these factors may have contributed to the 
differences found between the 2 analyses. In our study, among affected patients, the long QT group 
showed a different clinical pattern than the group with borderline QTc. Borderline QTc identifies 
individuals with a high cardiovascular risk burden, whereas factors such as diabetes and hypertension 
are independent predictors. Cardiovascular risk burden had no influence on whether the patient had 
long QTc. In this case, QTc elongation above 470 or 480 ms was strongly associated with prior 
episodes of AF. Regarding the potential role of antiarrhythmic drugs in this context, only 2 of the 
patients with a history of AF were receiving amiodarone or an HF class drug, and it was unknown 
how many participants were receiving these drugs for other arrhythmias; hence, it was not possible to 
accurately establish the percentage of individuals receiving antiarrhythmic therapy that might explain 
the presence of long QT. Regardless of any pharmacological effects, there may be unidentified 
characteristics in these individuals that cause QT elongation (eg, genetic factors related to congenital 
long QT syndrome) and be predisposing factors for AF. As in previous studies, borderline QTc was 
significantly related to age and female sex.
17, 20, 21
 This was not true of long QTc, which was related to 
age but not sex. 
 
The prevalence of short QTc was 0.23% —somewhat lower than the prevalences published in 
Japanese series
32, 33
 and more in line with European series
11, 18—,due to the cutoff used in this case 
(340 ms or less). 
 
Based on the results, more information is clearly needed on the true prognosis of these findings. A 
follow-up study in these populations will help identify patients who will benefit from more specific 
clinical follow-up. 
Limitations  
Limitations Related to Sample Selection  
Although the cross-sectional design with random selection of participants from the general 
population is not an efficient design under conditions of very low prevalence (particularly in the case 
of Brugada syndrome), this study was possible as part of the OFRECE project. As previously 
indicated, this study provides reasonable proof that it adequately represents the Spanish population ≥ 
40 years.
13
 It is probable that, in conditions related to early mortality (such as Brugada syndrome), the 
true prevalence is underestimated when only persons surviving to age 40 are included. Consequently, 
the magnitude of the problem presented here probably is most likely an underestimation of the true 
prevalence. 
  
Limitations Related to Electrocardiograph Performance and Interpretation  
Another limitation concerns the technique used to acquire the tracings. It is known that ECGs 
must be done according to specific standards. Our study was unable to control for correct use of high-
pass and low-pass filters, paper speed, voltage, etc, and it was necessary to analyze ECGs obtained 
with several different electrocardiographs. This may have influenced some diagnoses; however, a 
more rigorous approach would have been too costly and complex, and would have jeopardized the 
feasibility of the study. Nevertheless, these technical limitations meant that the study more closely 
represents real clinical practice. Some of these limitations were corrected by analyzing the ECGs in a 
centralized manner. 
 
The intermittent nature of some disorders is another limitation. For instance, the prevalence of 
Brugada pattern may have been underestimated because it is sometimes seen only under certain 
circumstances (fever or use of some drugs). In the case of long QT, we were unable to identify 
patients with QT elongation that was drug-induced or due to a congenital abnormality. Information 
on pharmacological therapies in this patient group was limited to data on drugs used in AF, and no 
information was available on the use of antihypertensives, antibiotics, antiepileptics, or other drugs 
implicated in QT elongation. Consequently, we were unable to identify patients with long QT interval 
in whom drugs were not implicated. 
CONCLUSIONS  
Electrocardiographic patterns associated with SCD are common in the Spanish population aged 
40 years or older: 0.6% to 1.1% have some electrocardiographic abnormality associated with a higher 
risk of SCD due to ventricular arrhythmia, thus representing a total of 480 000 people with the 
condition in Spain. In our study, long QTc interval was the most common finding (0.42% to 1% of 
patients according to the cutoff used) and was associated with a prior history of AF and with older 
age. Borderline QTc—also associated with SCD, although to a lesser extent—showed a high 
prevalence (8.3%), or around 3 332 000 persons aged 40 years or older in Spain. This condition was 
associated with older age, female sex, and cardiovascular risk factors (hypertension and diabetes). 
Brugada type 1 pattern showed very low prevalence (0.01%), similar to that described in other series 
in our setting. 
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